Anne-Lise Lecoq

1.7k total citations · 1 hit paper
25 papers, 445 citations indexed

About

Anne-Lise Lecoq is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Anne-Lise Lecoq has authored 25 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Oncology. Recurrent topics in Anne-Lise Lecoq's work include Parathyroid Disorders and Treatments (10 papers), Pituitary Gland Disorders and Treatments (5 papers) and Bone health and treatments (4 papers). Anne-Lise Lecoq is often cited by papers focused on Parathyroid Disorders and Treatments (10 papers), Pituitary Gland Disorders and Treatments (5 papers) and Bone health and treatments (4 papers). Anne-Lise Lecoq collaborates with scholars based in France, United States and Germany. Anne-Lise Lecoq's co-authors include Peter Kamenický, Philippe Chanson, Anne Guiochon‐Mantel, Agnès Linglart, Maria Luisa Brandi, Tài Pham, Étienne-Marie Jutant, Nicolas Noël, Marc Humbert and Olivier Meyrignac and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Bone and Mineral Research and Journal of Psychosomatic Research.

In The Last Decade

Anne-Lise Lecoq

21 papers receiving 439 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Post-acute COVID-19 syndrome

2022 140 citations David Montani, Laurent Savale et al. European Respiratory Review profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne-Lise Lecoq France	11	126	122	107	80	72	25	445
Hussein Raef Saudi Arabia	12	187 1.5×	87 0.7×	44 0.4×	117 1.5×	76 1.1×	34	495
Wenjuan Zhao China	10	165 1.3×	37 0.3×	77 0.7×	64 0.8×	87 1.2×	20	520
Yuqian Bao China	13	156 1.2×	28 0.2×	49 0.5×	72 0.9×	105 1.5×	52	475
Barry Hendin United States	9	66 0.5×	67 0.5×	62 0.6×	42 0.5×	57 0.8×	22	680
Shufei Zeng China	13	67 0.5×	14 0.1×	156 1.5×	59 0.7×	145 2.0×	32	441
Ilda S. Kunii Brazil	16	187 1.5×	21 0.2×	185 1.7×	166 2.1×	128 1.8×	55	671
Rosemary Bland United Kingdom	4	119 0.9×	14 0.1×	62 0.6×	37 0.5×	65 0.9×	5	776
Joanne Ferguson United Kingdom	8	38 0.3×	19 0.2×	134 1.3×	68 0.8×	95 1.3×	9	525
Nunzia Prencipe Italy	13	411 3.3×	37 0.3×	24 0.2×	186 2.3×	56 0.8×	61	561
Alessandro Maria Berton Italy	12	271 2.2×	32 0.3×	26 0.2×	102 1.3×	44 0.6×	54	381

Countries citing papers authored by Anne-Lise Lecoq

Since Specialization

Citations

This map shows the geographic impact of Anne-Lise Lecoq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne-Lise Lecoq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne-Lise Lecoq more than expected).

Fields of papers citing papers by Anne-Lise Lecoq

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne-Lise Lecoq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne-Lise Lecoq. The network helps show where Anne-Lise Lecoq may publish in the future.

Co-authorship network of co-authors of Anne-Lise Lecoq

This figure shows the co-authorship network connecting the top 25 collaborators of Anne-Lise Lecoq. A scholar is included among the top collaborators of Anne-Lise Lecoq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne-Lise Lecoq. Anne-Lise Lecoq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marie, Solène, Anne-Lise Lecoq, Fabien Caillé, et al.. (2025). Imaging the impact of sex and age on OATP function in humans: Consequences for whole-body pharmacokinetics and liver exposure. Acta Pharmaceutica Sinica B. 15(5). 2736–2745.

Lecoq, Anne-Lise, Arnaud Jannin, Cédric Cirenei, et al.. (2025). Chapter 12: Preparation for parathyroid surgery. Annales d Endocrinologie. 86(1). 101701–101701.

Gasnier, Matthieu, Anne-Lise Lecoq, Tài Pham, et al.. (2024). Unlike other medical conditions, type 2 diabetes is a risk factor for new-onset major depression after COVID-19. Journal of Psychosomatic Research. 187. 111963–111963.

Lecoq, Anne-Lise, Katharina Schilbach, L. Rocher, et al.. (2024). Metabolically healthy obesity in adults with X-linked hypophosphatemia. European Journal of Endocrinology. 191(2). 156–165. 3 indexed citations

Linglart, Agnès, Martine Cohen‐Solal, Anne-Lise Lecoq, et al.. (2024). Improved Oral Health in Adults With X-Linked Hypophosphatemia Treated With Burosumab. The Journal of Clinical Endocrinology & Metabolism. 110(5). 1460–1467. 6 indexed citations

Laparra, Ariane, et al.. (2023). Principaux troubles hydro-électrolytiques chez le patient de cancérologie. Bulletin du Cancer. 111(7-8). 687–700.

Kamenický, Peter, Karine Briot, Maria Luisa Brandi, et al.. (2023). Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment. RMD Open. 9(1). e002676–e002676. 20 indexed citations

Wolf, Peter, Nadjia Kachenoura, Céline Piedvache, et al.. (2023). Increase in intracellular and extracellular myocardial mass in patients with acromegaly: a cardiac magnetic resonance imaging study. European Journal of Endocrinology. 189(2). 199–207. 6 indexed citations

Maione, Luigi, Solange Grunenwald, Vincenzo Cimino, et al.. (2022). IGF-I Variability Over Repeated Measures in Patients With Acromegaly Under Long-Acting Somatostatin Receptor Ligands. The Journal of Clinical Endocrinology & Metabolism. 107(9). e3644–e3653. 13 indexed citations

10.

Montani, David, Laurent Savale, Nicolas Noël, et al.. (2022). Post-acute COVID-19 syndrome. European Respiratory Review. 31(163). 210185–210185. 140 indexed citations breakdown →

11.

Marie, Solène, Laurent Becquemont, Céline Verstuyft, et al.. (2022). [11C]glyburide PET imaging for quantitative determination of the importance of Organic Anion-Transporting Polypeptide transporter function in the human liver and whole-body. Biomedicine & Pharmacotherapy. 156. 113994–113994. 5 indexed citations

12.

Lecoq, Anne-Lise, Catherine Dong, Franck Carbonnel, & Laurent Becquemont. (2021). Hypophosphatémie et fer injectable : à propos d’un cas et revue de la littérature. Therapies. 76(6). 705–714. 1 indexed citations

13.

Lecoq, Anne-Lise, Marine Livrozet, Anne Blanchard, & Peter Kamenický. (2021). Drug-Related Hypercalcemia. Endocrinology and Metabolism Clinics of North America. 50(4). 743–752. 9 indexed citations

14.

Lecoq, Anne-Lise, Philippe Chaumet‐Riffaud, Anne Blanchard, et al.. (2020). Hyperparathyroidism in Patients With X-Linked Hypophosphatemia. Journal of Bone and Mineral Research. 35(7). 1263–1273. 38 indexed citations

15.

Lecoq, Anne-Lise, Maria Luisa Brandi, Agnès Linglart, & Peter Kamenický. (2019). Management of X-linked hypophosphatemia in adults. Metabolism. 103. 154049–154049. 35 indexed citations

16.

Lecoq, Anne-Lise, Jérôme Bouligand, Mirella Hage, et al.. (2016). Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas. European Journal of Endocrinology. 174(4). 523–530. 26 indexed citations

17.

Kamenický, Peter, Anne-Lise Lecoq, & Philippe Chanson. (2016). Primary hyperparathyroidism in pregnancy. Annales d Endocrinologie. 77(2). 169–171. 14 indexed citations

18.

Lecoq, Anne-Lise, Say Viengchareun, Mirella Hage, et al.. (2016). AIP mutations impair AhR signaling in pituitary adenoma patients fibroblasts and in GH3 cells. Endocrine Related Cancer. 23(5). 433–443. 22 indexed citations

19.

Nevoux, J., et al.. (2014). Glucocorticoids stimulate endolymphatic water reabsorption in inner ear through aquaporin 3 regulation. Pflügers Archiv - European Journal of Physiology. 467(9). 1931–1943. 26 indexed citations

20.

Lecoq, Anne-Lise, Peter Kamenický, Anne Guiochon‐Mantel, & Philippe Chanson. (2014). Genetic mutations in sporadic pituitary adenomas—what to screen for?. Nature Reviews Endocrinology. 11(1). 43–54. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact